![](/img/cover-not-exists.png)
Phase III trial comparing 3 to 6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial
Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., CiuffredaLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw404
Date:
August, 2016
File:
PDF, 639 KB
english, 2016